Neuralink
Neuralink is an Invasive Cortical Implants company founded in 2016 and based in Fremont, United States. It has raised $1.2B in total funding, most recently a Series E in 2025 at a $9B valuation.
Develops high-bandwidth implantable brain-machine interfaces with thousands of electrode channels for paralysis and neurological conditions. Began first human trials in 2024 with the PRIME study, demonstrating cursor control and gaming in paralyzed patients. Raised a $650M Series E in June 2025 at a $9B pre-money valuation, bringing total funding to approximately $1.2B.
The company's first human trials, robot-assisted surgical approach, and massive capital raise have made it the gravitational center of the invasive BCI field.
neuralink.com ↗·Invasive Cortical Implants·
United States·private 
